Some researchers have constructed CAR-T cells targeting PD-L1, which proved that PD-L1-CAR-T cells had anti-tumor activity in vitro, and the xenograft tumors of NSCLC with high expression of PD-L1 in mice also achieved prolonged remission [28]. This evidence concerns the gene CD274 and neoplasm.